Grand Pharmaceutical Group Ltd (HKSE:00512) Share Price

Company Profile

Business description
Grand Pharmaceutical Group Ltd, is an international pharmaceutical company of technological innovation. Its core businesses cover three areas: nuclear medicine anti-tumor diagnosis and treatment, cerebro-cardiovascular precision interventional diagnosis and treatment technology, pharmaceutical technology, and biotechnology. Based on the pharmaceutical and biological industries, the Group focuses on the needs of patients, and technological innovation as the driving force Geographically, it derives a majority of its revenue from the PRC and also has a presence in America; Europe; and Asia other than the PRC, and others.
Contact
99 Queen's Road
Units 3302, 33rd Floor, The Center
Central
Hong Kong
HKG
https://www.grandpharma.cn
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
12,440

Recommended

Higher sales and a new loan facility increase our conviction.

Shane Ponraj, CFA | 15 January 2026

We’ve raised our fair value estimate of Taiwan Semiconductor stock.

Phelix Lee | 15 January 2026

Watching sales growth and the potential for a major acquisition, here’s what we think of Netflix stock.

Matthew Dolgin, CFA | 15 January 2026

Index	Last price	Change	% Change
All Ordinaries	9,226.70	45.90	0.50%
CAC 40	8,258.94	54.18	-0.65%
DAX 40	25,297.13	55.26	-0.22%
Dow JONES (US)	49,359.33	83.11	-0.17%
FTSE 100	10,235.29	3.65	-0.04%
HKSE	26,844.96	78.66	-0.29%
NASDAQ	23,515.39	14.63	-0.06%
Nikkei 225	53,936.17	174.33	-0.32%
NZX 50 Index	13,718.10	58.31	0.43%
S&P 500	6,940.01	4.46	-0.06%
S&P/ASX 200	8,903.90	48.10	0.54%
SSE Composite Index	4,101.91	10.69	-0.26%